Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats.
The effects of two calcium channel blockers (verapamil and flunarizine) were evaluated on the naloxone-precipitated syndrome in morphine-dependent rats. The withdrawal signs in saline-treated rats were mainly diarrhea, body weight loss, jumping and ptosis. On i.p. administration, verapamil and flunarizine prevented diarrhea and body weight loss but not jumping. Verapamil also reduced the incidence of ptosis at the highest dose tested (40 mg/kg). Administered i.c.v., 160 micrograms verapamil reduced the body weight loss and the number of jumps without modifying diarrhea or ptosis. The results show that calcium channel blockers inhibit morphine abstinence syndrome manifestations through both peripheral and central mechanisms.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003000:Clonidine / Q000494:pharmacology; D003967:Diarrhea / Q000517:prevention & control; D005444:Flunarizine / Q000494:pharmacology; D007276:Injections, Intraventricular; D008297:Male; D009021:Morphine Dependence; D009270:Naloxone / Q000494:pharmacology*; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D009270:Naloxone; D014700:Verapamil; D003000:Clonidine; D005444:Flunarizine